SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950135-08-004411
Filing Date
2008-06-18
Accepted
2008-06-18 10:35:19
Documents
5
Period of Report
2008-07-18
Effectiveness Date
2008-06-18

Document Format Files

Seq Description Document Type Size
1 RXI PHARMACEUTICALS CORPORATION b70387dfdef14a.htm DEF 14A 465398
2 GRAPHIC b70387dfb7038700.gif GRAPHIC 1250
3 GRAPHIC b70387dfb7038702.gif GRAPHIC 2348
4 GRAPHIC b70387dfb7038703.gif GRAPHIC 3253
5 GRAPHIC b70387dfb7038701.gif GRAPHIC 1375
  Complete submission text file 0000950135-08-004411.txt   478724
Mailing Address 60 PRESCOTT STREET WORCESTER MA 01605
Business Address 60 PRESCOTT STREET WORCESTER MA 01605 508-767-3861
RXI PHARMACEUTICALS CORP (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000
Type: DEF 14A | Act: 34 | File No.: 001-33958 | Film No.: 08904814
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1